Evidence for pathogenicity of <i>BRCA2</i> c.8351G&gt;A p.(Arg2784Gln) and the challenges in classification of pathogenic variants with reduced penetrance

Our results indicate that <i>BRCA2</i> c.8351G>A p.(Arg2784Gln) has a disease-causing effect, with reduced penetrance, similar to other pathogenic variants in moderate risk breast cancer genes such as <i>ATM</i> and <i>CHEK2</i>. We also provide risk-adapted recommendations for clinical management. Importantly, one should be aware of a reduced penetrance as the underlying reason for conflicting results among pieces of evidence used for variant classification.

Authors

Institutions

Publication Details

Journal
Journal of Medical Genetics
Published
2025-12-18
DOI
https://doi.org/10.1136/jmg-2025-111145
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evidence for pathogenicity of BRCA2 c.8351G>A p.(Arg2784Gln) and the challenges in classification of pathogenic variants with reduced penetrance

E. Gómez, Eline Overwater, Arjen R. Mensenkamp, Christoph Engel et al.
Journal of Medical Genetics
BRCA gene mutations in cancer
article

Evidence for pathogenicity of BRCA2 c.8351G>A p.(Arg2784Gln) and the challenges in classification of pathogenic variants with reduced penetrance

E. Gómez, Eline Overwater, Arjen R. Mensenkamp, Christoph Engel, Najada Stringa, Marinus J. Blok, Petra Kleiblová, Kyriaki Michailidou, Maaike P.G. Vreeswijk, Wouter Koole, Marta Černá, Maria Zanti, Edenir Inêz Palmero, Fonnet E. Bleeker, Saskia Hopman, Lot Snijders Blok, Merel E. Braspenning, Marijke R. Wevers, Margriet J Collée, David E. Goldgar, Katrien Storm, Setareh Moghadasi
article en

Abstract

Our results indicate that <i>BRCA2</i> c.8351G>A p.(Arg2784Gln) has a disease-causing effect, with reduced penetrance, similar to other pathogenic variants in moderate risk breast cancer genes such as <i>ATM</i> and <i>CHEK2</i>. We also provide risk-adapted recommendations for clinical management. Importantly, one should be aware of a reduced penetrance as the underlying reason for conflicting results among pieces of evidence used for variant classification.

Journal of Medical GeneticsVol. 63(3)
University Medical Center Groningen (NL), Radboud University Nijmegen (NL), University of Antwerp (BE), Charles University (CZ), Leiden University Medical Center (NL), Huntsman Cancer Institute (US), Radboud University Medical Center (NL), The Netherlands Cancer Institute (NL), University Medical Center Utrecht (NL), Maastricht University (NL), Hospital de Câncer de Barretos (BR), Antwerp University Hospital (BE), Instituto Nacional de Câncer - INCA (BR), Erasmus MC Cancer Institute (NL), Amsterdam University Medical Centers (NL), General University Hospital in Prague (CZ), Cyprus Institute of Neurology and Genetics (CY), University of Amsterdam (NL), Leipzig University (DE)
Openalex Percentile: Top 57%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.